Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)
Close on Nov 17, 2026Market cap $424.04MP/E –Yield –
Prothena Corp Public operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Prothena Corp Public's operating cash flow for the twelve months ending Jun 30, 2026 was -$60.05M. For fiscal 2025 it was -$163.58M. The highest annual figure on record is $92.61M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$163.58M | – |
| FY2024 | Dec 31, 2024 | -$150.05M | – |
| FY2023 | Dec 31, 2023 | -$133.91M | – |
| FY2022 | Dec 31, 2022 | -$108.82M | -217.5% |
| FY2021 | Dec 31, 2021 | $92.61M | – |
| FY2020 | Dec 31, 2020 | -$80.36M | – |
| FY2019 | Dec 31, 2019 | -$52.97M | – |
| FY2018 | Dec 31, 2018 | -$28.28M | – |
| FY2017 | Dec 31, 2017 | -$131.18M | – |
| FY2016 | Dec 31, 2016 | -$116.25M | – |
| FY2015 | Dec 31, 2015 | -$58.60M | – |
| FY2014 | Dec 31, 2014 | -$683.00K | – |
| FY2013 | Dec 31, 2013 | -$32.10M | – |
| FY2012 | Dec 31, 2012 | -$42.07M | – |
| FY2011 | Dec 31, 2011 | -$19.70M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$25.05M | – |
| Q1 FY2026 | Mar 31, 2026 | $28.88M | – |
| Q4 FY2025 | Dec 31, 2025 | -$23.31M | – |
| Q3 FY2025 | Sep 30, 2025 | -$40.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$46.34M | -390.4% |
| Q1 FY2025 | Mar 31, 2025 | -$53.36M | – |
| Q4 FY2024 | Dec 31, 2024 | -$47.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$45.19M | -574.8% |
| Q2 FY2024 | Jun 30, 2024 | $15.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$73.05M | – |
| Q4 FY2023 | Dec 31, 2023 | -$51.04M | – |
| Q3 FY2023 | Sep 30, 2023 | $9.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$44.93M | – |
| Q1 FY2023 | Mar 31, 2023 | -$47.46M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$31.17M | -127.8% |
| Q2 FY2022 | Jun 30, 2022 | -$35.26M | -196.3% |
| Q1 FY2022 | Mar 31, 2022 | -$37.42M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.46M | – |
| Q3 FY2021 | Sep 30, 2021 | $112.11M | – |
| Q2 FY2021 | Jun 30, 2021 | $36.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$33.67M | – |
| Q4 FY2020 | Dec 31, 2020 | -$19.09M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.40M | – |
| Q2 FY2020 | Jun 30, 2020 | -$18.70M | – |
| Q1 FY2020 | Mar 31, 2020 | -$23.17M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.49M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.94M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.10M | -120.8% |
| Q1 FY2019 | Mar 31, 2019 | -$17.44M | – |
| Q4 FY2018 | Dec 31, 2018 | -$21.25M | – |
| Q3 FY2018 | Sep 30, 2018 | -$33.57M | – |
| Q2 FY2018 | Jun 30, 2018 | $58.13M | – |
| Q1 FY2018 | Mar 31, 2018 | -$31.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$39.52M | – |
| Q3 FY2017 | Sep 30, 2017 | -$17.74M | – |
| Q2 FY2017 | Jun 30, 2017 | -$36.08M | – |
| Q1 FY2017 | Mar 31, 2017 | -$37.84M | – |
| Q4 FY2016 | Dec 31, 2016 | -$33.81M | – |
| Q3 FY2016 | Sep 30, 2016 | -$30.06M | – |
See a number that looks wrong?